Some may know that our multicultural marketing and broadcasting company, Milestone Broadcast Corporation was established in 1985, with the inspiration of working with the Chinese and Asian community. MBC, celebrates our 40 Anniversary as a full service multicultural marketing and broadcasting company, with  to many corporations, i.e., Citibank, Delta Airlines, IBM, Sprint, US Postal, Western Union…who have trusted us to assist them to make friends and do business with over 100 multicultural communities. 

NOTE: You can travel to China with no VISA for 240 hours…also my hotel is $40 and Peking Duck Dinner for 2 is $20 on Westside of Beijing…

 Also, on July 4th will be the 27th Anniversary of our www.youtube.com/goodnewsbroadcast with 7,000 + Shows and www.goodnewsplanet.tv 

WE can help YOU. 

Here is an invitation to the UN, on June 9th, my birthday, hehe…for the International Day of for a Dialogue if it is still open.

Permanent Mission of China:

Celebration of the

International Day for

Dialogue among Civilizations

Here are some Health Stories

LEUKEMIA IS A TYPE OF

CANCER THAT AFFECTS THE

BLOOD OR BONE MARROW.

Rare Liver Disease –

biliary cholangitis

Lastly, if you care about your money, please tune in to WOR 710 Radio on Sunday at 10:30 AM. Here you can listen and call in to Legal Expert and Elder Care Lawyer, 14 Year NYS Representative and Dr. Phil, ET, Good Morning America…Guest Lawyer, Ann-Margaret Carrozza, ESQ. 

Ann is BRILLIANT, AND YOUR MONEY IS BRILLIANT, AND YOU ARE BRILLIANT IF YOU ARE SMART ENOUGH TO PROTECT IT.

Paul Sladkus is Ann’s Co-Host. Email me paul.sladkus1@gmail.com if you want me to ask her a question, or just call in (800-321-0710) and listen; it might be one of the most important programs in you and your family’s life.

Ann-Margaret Carrozza,

Asset Protection Lawyer,

WOR 710 AM

CALL IN Radio

LIVE Every

Sunday at 1030am

STAY WELL

Please support our nonprofit, 501 C 3, Good News Corporation at http://goodnewsplanet.com/peacedayparty/peace-day-donations/

LET’S GROW TOGETHER. GOOD NEWS MOTTO: “All we are is what we are with each other.” Zeal 

With Respect. Love and May Peace Prevail on Earth,  For Information Contact: 

Reverend Paul Sladkus, All Faiths and Spiritual,

Founder, Good News Corporation 501 C 3 212 647 1212 paul.sladkus1@gmail.com  and our Good News and Peace Worldwide Team who make our Peace Day 9/21 happen.

www.pausetheworldforpeace.org,www.goodnewsplanet.TV, www.youtube.com/goodnewsbroadcast

Social Networks: www.Facebook.com/PaulSladkus, LinkedIn Paul Sladkus, Twitter/X Good News to Go, Instagram PausetheWorld

LET’S GROW TOGETHER. GOOD NEWS MOTTO: ALL WE ARE IS WHAT WE ARE WITH EACH OTHER. ZEAL

For more information contact: 

Reverend Paul Sladkus, All Faiths and Spiritual 212 647 1212

New York, NY, Montauk, NY

PS – SPECIAL OPPORTUNITY FOR OUR FRIENDS AND MEMBERS: Looking for a vacation rental, SHORT TERM, in Montauk, this year and or entire summer in 2026, here is our listing https://pausetheworldforpeace.org/2025/04/16/36000-2br-one-of-a-kind-summer-rental-opportunty-historic-montauk-manor-montauk/  call me. Paul 917 687 1790

The post GoodNewsLetter: Beijing, China 40th Anniversary of MBC, 27th of Good News Broadcast, A invitation to the UN and HEALTH Good News appeared first on Good News!.

Joining us today to learn more about P-B-C is Dr. Steven Flamm, a liver expert at Rush University Medical Center, and Rosetta who is living with P-B-C and has advice on how to become an advocate for your health.

iqirvo.com

Steven Flamm, MD, FAASLD, FACG, is a professor in the Department of Internal Medicine, Division of Digestive Diseases and Nutrition who is board certified in Gastroenterology and Transplant Hepatology.

Flamm cares for patients with acute or chronic liver disease, including patients with viral hepatitis, alcohol-related liver disease, fatty liver, autoimmune liver disease and patients with cirrhosis. He also cares for patients who require liver transplantation evaluation and who have hepatocellular carcinoma. Flamm is also helping to lead and build a robust clinical research program for patients with liver disease.

He believes in the importance of making care easily accessible, whether that is a thorough in-office consultation for patients with chronic liver disease, those in need of potential life-saving transplantation or by bringing tertiary care for patients to multiple locations in the community. Flamm is readily available to discuss any patients with liver-related issues or who require in-patient transfers with providers.

Rosetta’s Bio

Rosetta is a loving wife and mom to five kids—plus three dogs and a cat. She is also living with a rare cholestatic liver disease called primary biliary cholangitis (PBC) and speaks about her experience in hopes of empowering others to advocate for their health.

The post Rare Liver Disease – biliary cholangitis appeared first on Good News!.

Approximately 1 in 5 people living with cancer in the United States are diagnosed with a rare cancer; however, these are often misunderstood and overlooked. Cholangiocarcinoma, or CCA, is a rare cancer affecting fewer than 10,000 people in the U.S. CCA arises from the cells within the bile ducts, a series of thin tubes that reach from the liver to the small intestine. Because of its nonspecific symptoms, patients with CCA are often diagnosed at a late or advanced stage when the prognosis is poor and survival rates are low.

www.testmycholangio.com

Innovative technology called biomarker testing has made it possible to look very closely inside each person’s tumors to identify genomic changes. Determining the genomic makeup of a person’s tumor can help doctors understand more about the tumor.

National Cancer Survivors Day serves as an opportunity to rally around those living with CCA and other rare cancers, recognizing the challenges they face, and providing the community with the national attention they need and deserve. Dr. Rachna Shroff discusses CCA, along with importance of biomarker testing. Dr. Shroff is joined by Melinda Bachini, Director of Advocacy for the Cholangiocarcinoma Foundation and a CCA survivor, who will share her personal symptom and diagnosis journey.

Interview is courtesy of Incyte Corporation

Rachna T. Shroff, MD, MS, is an Associate Professor of Medicine and Chief of GI Medical Oncology as well as Leader of the Gastrointestinal Clinical Research Team at the University of Arizona Cancer Center (UACC). She is the Director of UACC’s Clinical Trials Office as well as the Director of the Arizona Clinical Trials Network (ACTN). More recently, she was appointed as the Associate Dean for Clinical and Translational Research for UA College of Medicine-Tucson. She came to UACC from MD Anderson Cancer Center in Houston, TX where she was on faculty from 2010-2018 after completing her medical oncology fellowship there.

Dr. Shroff is a clinical and translational investigator focused on developing novel therapies for pancreatic and biliary cancers. She holds multiple positions nationally due to her expertise in these areas, including serving as the Hepatobiliary subcommittee Co-Chair for the Southwest Oncology Group (SWOG) and as a Program Committee member for GI ASCO. She also is a member of the Scientific and Medical Advisory Board for the Cholangiocarcinoma Foundation. Dr. Shroff has led numerous clinical trials focusing on pancreaticobiliary tumors and is the national PI for SWOG 1815 which is investigating a triplet chemotherapy regimen as a potential new standard of care for biliary cancers. This is based on a phase 2 study she led that is now published in JAMA Oncology. Dr. Shroff has been invited to speak at national and international meetings on topics related to targeted therapies for pancreatic and biliary cancers and has numerous peer-reviewed publications in this area.

BIO
Melinda Bachini is an 11-year survivor of cholangiocarcinoma. In 2012 she was treated at the National Cancer Institute by Dr. Rosenberg with a clinical trial using Adoptive Cell Therapy with TIL. Due to her exceptional and breakthrough response to NIH treatment, her story was published in the New York Times and other media.

Melinda is married and the mother of six children, grandmother to one. She is passionate about patient advocacy. Her personal experience with previous and current treatments allows for great insight into patients participating in clinical trials. Her position as Director of Advocacy for the Cholangiocarcinoma Foundation allows Melinda to interact, support and educates others touched by this cancer. She shares her story with as many cancer patients as possible in hopes of giving courage to those in need.

Melinda had previously volunteered for seven years with the Cholangiocarcinoma Foundation and in August of 2017 came on as staff. She also worked for over 15 years in the Emergency Medical Field as an EMT Paramedic.

Melinda serves as a patient advocate for the NCI Hepatobiliary Task Force, the NCI Patient Advocate Steering Committee (PASC), ECOG-ACRIN GI Committee, ECOG-ACRIN Cancer Research Advocacy Committee, NCI Council of Research Advocates, and the NCCN Hepatobiliary Guideline Panel. Melinda attended 2016, 2017, and 2018 NCCS, CPAT Symposium, and advocated on Capitol Hill. She participated as a panelist in the Cancer Moonshot – Community Oncology Event at the White House, told her personal story, and was introduced by her state Senator for the Innovation and Access in Quality Cancer Care at the US Capitol. In June of 2017 she spoke with nine US Senators at NIH to share her personal story of how research has prolonged her life. Melinda has served as a Consumer Reviewer for the Department of Defense for several years.

#cancer #survivor #cholangiocarcinoma #navigating #diagnosis #rachna #shroff #melinda #bachini #incyte #cca #medical #educate #support #emergency #liver #pancreatic #biliary #hepatobiliary #oncology

The post National Cancer Survivors Day is June 6, We discuss Cholangiocarcinoma appeared first on Good News!.